Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
BeOne Medicines
Instituto do Cancer do Estado de São Paulo
Boehringer Ingelheim
Targeted Therapy Technologies, LLC
Amgen
Elevar Therapeutics
National Institutes of Health Clinical Center (CC)
3D Medicines
M.D. Anderson Cancer Center
Shandong Suncadia Medicine Co., Ltd.
Intergroupe Francophone de Cancerologie Thoracique
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Nanjing Leads Biolabs Co.,Ltd
AbbVie
Nanjing Leads Biolabs Co.,Ltd
CatalYm GmbH
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Emory University
Children's Oncology Group
CatalYm GmbH
Children's Oncology Group
M.D. Anderson Cancer Center
Nanjing Leads Biolabs Co.,Ltd
University Medical Center Groningen
LaNova Medicines Limited
Ohio State University Comprehensive Cancer Center
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai AB PharmaTech Ltd.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Jiangsu HengRui Medicine Co., Ltd.
Samsung Medical Center
Qilu Hospital of Shandong University
Brigham and Women's Hospital
Minghui Pharmaceutical (Hangzhou) Ltd
M.D. Anderson Cancer Center
Daiichi Sankyo
University Hospital, Lille
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Royal Marsden NHS Foundation Trust
Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Memorial Sloan Kettering Cancer Center
Medical College of Wisconsin
Memorial Sloan Kettering Cancer Center
University of Pittsburgh
Aalborg University Hospital
Fudan University